0001493152-24-025338.txt : 20240626 0001493152-24-025338.hdr.sgml : 20240626 20240626213007 ACCESSION NUMBER: 0001493152-24-025338 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240624 FILED AS OF DATE: 20240626 DATE AS OF CHANGE: 20240626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSTEIN DOV A MD CENTRAL INDEX KEY: 0001120478 ORGANIZATION NAME: STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40237 FILM NUMBER: 241075089 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gain Therapeutics, Inc. CENTRAL INDEX KEY: 0001819411 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 851726310 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: (301) 500-1556 MAIL ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 ownership.xml X0508 4 2024-06-24 0 0001819411 Gain Therapeutics, Inc. GANX 0001120478 GOLDSTEIN DOV A MD C/O GAIN THERAPEUTICS, INC. 4800 MONTGOMERY LANE, SUITE 220 BETHESDA MD 20814 1 0 0 0 0 Stock Option (right to buy) 1.29 2024-06-24 4 A 0 15000 0.00 A 2034-06-24 Common Stock 15000 15000 D The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date. /s/ Daniel Porco, Attorney-in-Fact 2024-06-26